Help | RSS Feed

Repligen Corp. (NASD:RGEN) Seasonal Chart

Repligen Corp. (NASD:RGEN) Seasonality

RGEN Relative to the S&P 500
RGEN Relative to the S&P 500

RGEN Relative to the Sector
RGEN Relative to the Sector

Monthly Seasonal Repligen Corp. (NASD:RGEN)

Seasonal Chart Analysis

Analysis of the Repligen Corp. (NASD:RGEN) seasonal charts above shows that a Buy Date of May 2 and a Sell Date of September 6 has resulted in a geometric average return of 10.32% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 17 of those periods. This is a very good rate of success, but the return underperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 1.19% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore